CIGNA Co. (CI) Insider Michael W. Triplett Sells 2,825 Shares

CIGNA Co. (NYSE:CI) insider Michael W. Triplett sold 2,825 shares of the business’s stock in a transaction that occurred on Monday, November 5th. The stock was sold at an average price of $214.25, for a total transaction of $605,256.25. Following the completion of the transaction, the insider now owns 23,871 shares of the company’s stock, valued at approximately $5,114,361.75. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Shares of CIGNA stock opened at $217.65 on Friday. The firm has a market cap of $53.65 billion, a price-to-earnings ratio of 15.99, a price-to-earnings-growth ratio of 1.24 and a beta of 0.58. CIGNA Co. has a 52 week low of $163.02 and a 52 week high of $227.13. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.98 and a quick ratio of 0.98.

CIGNA (NYSE:CI) last issued its earnings results on Thursday, November 1st. The health services provider reported $3.84 EPS for the quarter, beating the consensus estimate of $3.45 by $0.39. The company had revenue of $11.45 billion during the quarter, compared to analysts’ expectations of $11.19 billion. CIGNA had a net margin of 6.15% and a return on equity of 23.31%. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.83 EPS. As a group, sell-side analysts forecast that CIGNA Co. will post 14.35 EPS for the current year.

Several research analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of CIGNA from a “hold” rating to a “buy” rating and set a $212.00 price objective for the company in a research report on Tuesday, August 7th. Cantor Fitzgerald assumed coverage on shares of CIGNA in a research report on Wednesday, September 26th. They issued an “overweight” rating and a $245.00 price objective for the company. ValuEngine cut shares of CIGNA from a “hold” rating to a “sell” rating in a research report on Monday, August 13th. Cowen assumed coverage on shares of CIGNA in a research report on Monday, September 17th. They issued an “outperform” rating and a $240.00 price objective for the company. Finally, Jefferies Financial Group restated a “buy” rating and issued a $224.00 price objective on shares of CIGNA in a research report on Friday, August 3rd. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. CIGNA currently has a consensus rating of “Buy” and an average target price of $233.14.

Several institutional investors have recently modified their holdings of the business. FMR LLC raised its position in shares of CIGNA by 18.6% during the 3rd quarter. FMR LLC now owns 8,970,440 shares of the health services provider’s stock valued at $1,868,093,000 after acquiring an additional 1,409,335 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of CIGNA by 3.0% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 5,611,743 shares of the health services provider’s stock valued at $953,716,000 after acquiring an additional 164,623 shares during the last quarter. Veritas Asset Management LLP raised its position in shares of CIGNA by 5.1% during the 3rd quarter. Veritas Asset Management LLP now owns 4,648,900 shares of the health services provider’s stock valued at $968,133,000 after acquiring an additional 226,700 shares during the last quarter. Sanders Capital LLC raised its position in shares of CIGNA by 4.6% during the 3rd quarter. Sanders Capital LLC now owns 3,490,224 shares of the health services provider’s stock valued at $797,672,000 after acquiring an additional 151,971 shares during the last quarter. Finally, Boston Partners raised its position in shares of CIGNA by 0.6% during the 2nd quarter. Boston Partners now owns 2,904,221 shares of the health services provider’s stock valued at $493,572,000 after acquiring an additional 17,675 shares during the last quarter. Institutional investors own 89.11% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “CIGNA Co. (CI) Insider Michael W. Triplett Sells 2,825 Shares” was reported by WKRB News and is the sole property of of WKRB News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://www.wkrb13.com/2018/11/10/cigna-co-ci-insider-michael-w-triplett-sells-2825-shares.html.

CIGNA Company Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Article: How are the companies in the S&P 500 selected?

Insider Buying and Selling by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply